As of Jul 31
| +0.01 / +2.33%|
The 3 analysts offering 12-month price forecasts for Cytori Therapeutics Inc have a median target of 6.00, with a high estimate of 7.00 and a low estimate of 1.25. The median estimate represents a +1,263.64% increase from the last price of 0.44.
The current consensus among 3 polled investment analysts is to Buy stock in Cytori Therapeutics Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.